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ABSTRACT
The cellular uptake and intracellular distribution of
methylphosphonate oligonucleotides (15 mers) has been
examined using both 32p labeled and fluorescent
labeled oligonucleotides. The cellular uptake process for
methylphosphonate oligonucleotides is highly temper-
ature dependent, with a major increase in uptake
occuring between 15 and 200C. Most of the label which
becomes cell associated at 370C cannot be removed by
acid washing or trypsinization and thus seems to be
within the cell. Visualization of rhodamine labeled
methylphosphonate oligonucleotides using digital imag-
ing fluorescence microscopy reveals a vesicular
subcellular distribution suggestive of an endosomal
localization. There was extensive co-localization of
rhodamine labeled methylphosphonate oligonucleotides
with fluorescein-dextran, an endosomal/lysosomal
marker substance. The apparent endocytotic uptake of
labeled methylphosphonate oligonucleotides could not
be blocked by competition with unlabeled
methylphosphonate or phosphodiester oligonucleotides,
nor by ATP. This contrasts with the situation for
radiolabeled phosphodiester oligonucleotides whose
uptake can be completely blocked with unlabeled com-
petitor. Uptake of phosphodiester oligonucleotides, but
not of methylphosphonate oligonucleotides, could be
blocked by acidification of the cytosol. These observa-
tions suggest that the pathway of cellular uptake of
methylphosphonate oligonucleotides involves fluid
phase or adsorbtive endocytosis, and is distinct from
the uptake pathway for phosphodiester oligo-
nucleotides.
INTRODUCTION
Antisense oligonucleotides seem to have considerable promise
as therapeutic agents for viral diseases and cancer [1-4].
Antisense compounds can potentially interdict the expression of
specific genes by interfering with transcription, message
processing, RNA stability, or translation [5]. In order to exert
any of these effects, the oligonucleotides must enter into the
cytoplasmic and nuclear compartments of the cell. From the
perspective of many years of study of membrane transport
phenomena, it is quite remarkable that oligonucleotides enter cells
at all, since other compounds of smaller size and lower charge
are usually thought to be unable to cross the cell membrane [6,7].
Nonetheless, it is clear that oligonucleotides do enter cells in
quantities sufficient to produce impressive biological effects in
several different systems [1-5]. Investigations on the mechanism
of cellular uptake of unmodified phosphodiester-linked
oligonucleotides have indicated that endocytosis seems to be the
major pathway, and that there are specific cell surface binding
proteins for oligodeoxynucleotides of about 65-8OkD which may
play a role in uptake [8,9]. The uptake process for phosphodiester
oligodeoxynucleotides is temperature and energy dependent and
is inhibitable by excess unlabeled oligodeoxynucleotide [8].
Since unmodified phosphodiester oligodeoxynucleotides are
readily degraded by nucleases present in cells and in extracellular
fluids [10,31], there has been a considerable effort devoted to
synthesis of chemically modified oligodeoxynucleotides which
are nuclease resistant while still retaining Watson-Crick base
pairing specificity. While many different types of chemically
modified oligodeoxynucleotides have been synthesized [11], the
most widely used modifications are the replacement of a backbone
oxygen with sulfur to form a phosphorothioate [3,12], or the
substitution of a methyl residue to form a methylphosphonate
[4,11,13]. Phosphorothioate oligodeoxynucleotides retain the
anionic charge characteristics of phosphodiester oligodeoxy-
nucleotides, while methylphosphonate oligodeoxynucleotides are
uncharged. Little is known about the cellular uptake character-
istics of modified oligodeoxynucleotides. Phosphorothioates have
been reported to competively block the cellular uptake of
phosphodiester oligodeoxynucleotides and thus may enter cells
by the same mechanisms [12,14]. By contrast, methylphosphonate
oligodeoxynucleotides do not compete with charged oligodeoxy-
nucleotides for uptake [8]. Because of their relatively poor
aqueous solubility and their lack of charge, it has been suggested
that methylphosphonate oligodeoxynucleotides enter cells by
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passive diffusion across the cell membrane [13,14 ]; however,
studies to date have been rather preliminary and have not clearly
delineated an uptake mechanism.
In this report we examine the cellular uptake and intracellular
distribution of oligonucleotides containing methylphosphonate
linkages. We synthesized 1 5-mer methylphosphonate
oligodeoxynucleotides complementary to human mdrl mRNA,
and investigated their uptake by a drug resistant Chinese Hamster
Ovary cell line (CHRC5) [15]. The oligonucleotide used here for
cell uptake studies is similar to ones currently being employed
in our laboraratory in functional studies [Akhtar & Juliano, in
preparation]. Since the cellular uptake of a labeled compound
may be affected by the chemical characteristics of the label, we
have used two different types of labeled methylphosphonate
oligonucleotides. One was labeled at the 5' end with 32p, while
the other was labeled with rhodamine covalently attached to a
5' amino linker group. The rhodamine labeled oligodeoxynucleo-
tides were also employed for studies of intracellular distribution
using digitized fluorescence microscopy. Our results suggest that
oligodeoxynucleotides containing methylphosphonate linkages are
taken up by cells through a process of active endocytosis, but




Methylphosphonate containing oligodeoxynucleotides (MP-oligo-
nucleotides, l5mers) with a sequence complementary to a site
overlapping the AUG initiation codon of the human mdrl mRNA
[15] were synthesized on an automated DNA synthesizer (Model
380B, Applied Biosystems, Foster City, CA) using beta-
cyanoethyl cycles [16,17]. Methyl phosphonamidate synthons
were obtained from Applied Bionetics, Hayward, CA. The
sequence was 5' CTC CAT CAC CAC CTC 3' and contained
a single 5' end phosphodiester moiety to facilitate radiolabeling
with T4 kinase. MP-oligonucleotides with an amino linker group
were also synthesized by attaching an amino hexyl phosphate
linker (Aminolink 2; Applied Biosystems, Foster City, CA) to
the 5' end of the oligodeoxynucleotide in the last coupling cycle.
The oligodeoxynucleotides were detritylated, deprotected and
purified according to a standard protocol [16].
5' end labelling of oligodeoxynucleotides with [32P]
MP-oligonucleotides were 5' end labeled with [32P]-gamma-
labelled ATP using T4 polynucleotide kinase (Promega) in buffer
containing 100 mM Tris pH 7.5, 20 mM MgCl2 10 mM DTT,
0.2 mM spermidine and 0.2 mM EDTA at 37°C for 30 minutes.
Specific radioactivity was 108-109 cpm/4g. Labelled oligodeoxy-
nucleotides were purified by denaturing PAGE (15% polyacryl-
amide containing 7 M urea). The band corresponding to the desired
oligodeoxynucleotide was eluted with 20% ethanol/water, desalted
by ethanol precipitation, or by gel filtration on Sephadex G-25
(DNA grade superfine, Pharmacia, Sweden), resuspended in
isotonic phosphate buffered saline, and stored at -20°C until use.
Rhodamine labeled oligodeoxynucleotide
MP-oligonucleotides with an amino linker (50/tg) were incubated
with 100yug tetramethylrhodamine-5-(and-6)-isothiocyanate CrRIT-
sodium carbonate/sodium hydrogen carbonate buffer (pH 9.0) at
room temperature overnight. The labeled oligodeoxynucleotide was
purified by Sephadex G-25 (DNA grade) column chromatography
to remove free TRITC. The purity of the conjugate and the absence
of free TRITC was checked by PAGE.
Transport studies
Cellular uptake studies were carried out using CHRC5 cells (a
multiple drug resistant mutant of the Chinese Hamster Ovary
tumor cell line) [15,18]. These cells were kindly provided by
Dr. V.Ling (Ontario Cancer Institute, Toronto, Ontario,
Canada). The cells were routinely maintained by serial culture
in alpha-MEM supplemented with 10% v/v FCS and 1% anti-
biotics at 37°C in a 5% CO2 atmosphere. Under these condi-
tions the cells were exponentially growing with a doubling time
of about 18 hrs. This cell line was found to be free of
Mycoplasma.
For uptake experiments, 1-2 x 105 cells/well (24 well plate)
were incubated with 5'-[32p] labelled MP-oligonucleotides in
alpha-MEM medium containing 10% v/v heat inactivated FCS;
in some experiments serum-free HEPES buffer containing 25 mM
HEPES (4-(2-hydroxyethyl)-1-piperazine ethane sulfonic acid),
140 mM NaCl, 5 mM KCI, 1 mM CaC12, 1 mM MgCl2
10 mM glucose, 1% bovine albumin (pH 7.4) was used instead.
When inhibitors were used, these were added 15 min. prior to
addition of labeled MP-oligonucleotides. After the incubation,
the medium was removed and cells washed 4 times with 0.5 ml
PBS. Cells were then lysed with 1% SDS and cell associated
radioactivity was determined by liquid scintillation counting. Cells
were incubated over a range of 4°C -37°C for the studies on
temperature dependency of uptake; all other uptake studies were
carried out at 37°C.
To strip off surface bound oligodeoxynucleotides, 0.4 M acetate
buffer (pH 2.3) containing IM NaCl was used as a washing
solution. Low pH washing has been reported to remove almost
90% of cell surface bound ligands[ 19]. Alternatively, trypsin-
EDTA was used to remove membrane associated
oligodeoxynucleotides by digesting cell surface protein binding
sites. Cells were treated with 200pI of trypsin-EDTA(x 1)
(Sigma) until all cells became round and came off the plates; lml
of PBS was added, and the cells and were recovered by
centrifugation at 1000 rpm for 5min. Cells were washed with
PBS and lysed with 1% SDS. Cell associated radioactivity was
determined by liquid scintillation counting.
Digital video imaging system
Experiments on the subcellular distribution of oligonucleotides
were performed using the MDVM (multiparameter digitized
video microscopy) imaging system described elsewhere [20,21].
The MDVM system basically consists of an epi-fluorescence
microscope (IM-35; Carl Zeiss, Inc.), excitation and neutral
density filter wheels, video camera and a digitizing board
interfaced to a computer. The excitation wavelength was provided
by a 100-W mercury vapor lamp and passed through computer
controlled interference and neutral density filter wheels. A band
pass excitation filter of 545 nm, a long pass barrier filter of
590nm, and a dichromatic beam splitter of 580nm were used to
visualize the subcellular distribution of TRITC labeled MP-
oligonucleotides. The microscope stage was maintained at 370C
C, purchased from Research Organics Inc, Cleveland, OH) in by an air curtain incubator. The fluorescent image of the cell
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was projected by a rifle-telescope attached to the microscope on
to the computer controlled image intensifier GeniIsys Camera.
The GeniIsys consists of a head, including proximity type MCP
(microchannel plate) image intensifier with relay optics, coupled
to a high gain CCD-72 (charged coupled device) camera (model
Genllsys, Dage-MIT, Inc., Michigan City, IN). Both the
Genllsys and CCD-72 camera has their own control units to
manipulate and fix the gain and blacklevel of the image during
the experiments. The resultant image from the CCD camera was
digitized by the imaging board (512 x 512 pixel, 8bit, model
IP512, Imaging Technology, MA), and interfaced to a PDP 11/23
Computer (Digital Equipment Corp., Maynard, MA). A 63 x
oil immersion plan-Neofluar objective (NA= 1.25) or 40 x oil
immersion Nikon-Fluor was used to observe the fluorescent
image, and 1.5-3.0 x was used at the rifle telescope. During
the experiments, the live cell fluorescence was averaged over
256 images or 32 images, background subtracted, and stored to
the disk as a 256 x 256 pixel image. This stored fluorescent image
was used to analyze the data. To measure the fluorescence
intensities, 50 different fields were recorded. Phase contrast




























Fig. 1. Effects of temperature and time on cellular uptake of methylphosphonate
oligodeoxynucleotides. (A) CHRC5 cells were incubated with 0.011tM [32p]
labelled MP-oligodeoxynucleotides at 4°C (open) or 37°C (closed) in 10% heat
inactivated FCS containing alpha-MEM for various times. Amounts of cell
associated MP-oligonucleotides are expressed as ng/105 cells. Each experiment
is in quadruplicate. (B) Cells were incubated 4,uM TRITC labeled MP-
oligodeoxynucleotides or free TRITC in HEPES buffer at 4°C (clear) or 37°C
(solid) for 1 hour. Amount of fluorescence intensity was determined by digitized
video imaging system as described in 'Materials and Methods'. Fluorescence
intensities were averaged for 50 fields. Each field contained 10-20 cells. Uptake
at 4°C was determined as percentage of fluorescence at 37°C in each case. Bars
are standard deviations.
Cell culture for digital video imaging
For experiments concerning the subcellular distribution of MP-
oligonucleotides, cells were cultured on glass coverslips in alpha-
MEM containing 10% FCS for 2 or 3 days. Thereafter 4uM
TRITC labelled MP-oligonucleotides were incubated with cells
in HEPES buffer (pH 7.4) at 37°C in 5% CO2 With fluorescent
oligonucleotides, uptake studies in HEPES buffer rather than
serum containing growth medium provided a higher level of cell
uptake and lower background fluorescence(data not shown); thus
HEPES buffer was used for the experiments on subcellular
distribution in order to get sufficient fluorescence intensity. To
identify endocytic/lysosomal vesicles, cells were pre-incubated
with 2 mg/ml FITC dextran (Molecular Probes, OR), a well
known marker for the endosome-lysosome compartment [22],
in complete alpha-MEM medium at 37°C for 1 hour. Then cells
were washed with HEPES buffer and were incubated with
2mg/mi of nonlabeled dextran in a complete alpha-MEM medium
at 37°C. After overnight incubation, cells were washed with
HEPES buffer, and 4uM TRITC labeled MP-oligonucleotides
were added in HEPES buffer. After 1 hour incubation, coverslips
were washed throughly with HEPES buffer containing 0.1% BSA
and mounted in a special chamber designed for the digital video
imaging system. During fluorescence microscopy, HEPES buffer
was used to prevent shifts in extracellular pH which might change
the sub-cellular distribution patterns.
Inhibition of receptor mediated endocytosis
It has been reported that reduction of cytoplasmic pH inhibits
receptor-mediated endocytosis but not fluid-phase endocytosis
[23,24] . Thus the transport mechanism of MP-oligonucleotides
was examined under conditions of low cytoplasmic pH. For the
acidification of intracellular pH (pHi), extracellular pH (pHo)
was controlled with bicarbonate-free alpha MEM supplemented
with 0.2% BSA and buffered with 20 mM MES (2,(N-
morpholino)-ethanesulfonic acid, Sigma). In each experimental
situation, pHi was measured in cells loaded with BCECF-AM
(2',7'-bicarboxyethyl-5,6-carboxyfluorescein acetoxymethyl
ester, Molecular Probes) using the digitized video image system,
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Fig. 2. Temperature dependence of cellular uptake of methylphosphonate
oligodeoxynucleotides. CHRC5 cells were incubated with 0.01MM MP-
oligodeoxynucleotides in HEPES-buffer (pH7.4) at 4, 9, 14, 19, 23, 28, 32, 37°C
for 3 hours. Cell-associated radioactivity was determined by liquid scintillation
counting. Uptake is expressed as ng/105 cells. Bars are standard errors.
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Intracellular stability of MP-oligonucleotides
Cells were incubated in alpha-MEM with 10% v/v heat
inactivated FCS containing 5'-[32P] labeled MP-oligonucleotides
or D-oligonucleotides in a 24 well plate at 37'C for various times.
The incubation mixtures were removed and the cells were scraped
out using a rubber policeman. Cell pellets were spun down and
washed with PBS. Cells were lysed by 0.5% NP40/PBS and
were heated at 65°C for 30 min. Incubation supernatants and
the original MP-oligonucleotides or D-oligonucleotides were also
treated in the same manner. Samples were analyzed by PAGE
(15% denaturing gel containing 7M urea).
RESULTS
Temperature and time dependence of cellular uptake of MP-
oligonucleotides
Figure IA shows the effects of temperature and time on cellular
uptake of 5'-[32p] labeled MP-oligonucleotides in CHRC5 cells.
Significant uptake of MP-oligonucleotides was observed at 37°C
and plateaued at 10-12 hours. The major difference between
cellular uptake at 4°C and at 37°C suggested that internalization
of MP-oligonucleotides occured by an active mechanism. To
make sure that the uptake process was not governed by the
presence of the additional charged 5' phosphate moiety in the
[32p] labeled MP-oligonucleotides, we also examined uptake of
TRITC labeled MP-oligonucleotides, as well as uptake of free
(unconjugated) TRITC as a control. Uptake of TRITC labelled
MP-oligonucleotides and of free TRITC were quantified by
digitized video imaging as described in the Methods section.
Fig lB shows the temperature dependence of uptake of TRITC
labelled MP-oligonucleotides. As with the uptake of [32p]
labeled MP-oligonucleotides, uptake of TRITC labeled MP-
oligonucleotides was significantly lower at 4°C than at 37°C.
By contrast, uptake of free TRITC was not temperature
dependent. Since two different labelling methods showed
temperature dependent cellular accumulation, it seems likely that
MP-oligonucleotides are taken up by an active cellular process
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Fig. 3. Intracellular uptake of methylphosphonate oligodeoxynucleotides. Cells
were incubated with O.O1tM MP-oligonucleotides at 4°C (clear) or 37°C (solid)
for 6 hours in HEPES buffer. After the incubation cells were washed with acetate
buffer (pH 2.3) as described in Methods. Trypsin was added to cells as an
alternative method to strip off surface bound MP-oligonucleotides. Cell-associated
radioactivites were determined as described in Methods. Amounts of uptake were
expressed as percentage of that of control at each temperature. Bars are standard
deviations. Experiments were carried out in triplicate.
not clear why the uptake plateaus at 10-12 hrs.; this may
represent exocytosis of the oligonucleotide, or other loss from
the cell, but for MP-oligonucleotides it probably does not
represent degradation (see below).
In Fig 2 the temperature dependence of cellular uptake of
[32p] labelled MP-oligonucleotides is analyzed in more detail,
with measurements taken at intervals of a few degrees. The uptake
profile shows a sharp discontinuity between 15 and 20°C. This
is very characteristic of active endocytosis, but is distinct from
the expected temperature profile for passive diffusion which
would be likely to exhibit a gradual increase [7, 26].
Cell surface binding of MP-oligonucleotides
The cell associated [32p] MP-oligonucleotides in Fig. 1 could be
due to surface binding as well as to uptake into intracellular
compartments. In order to asses the fraction of cell associated
MP-oligonucleotides actually within the cell, low pH buffer or
trypsinization were used to strip off cell surface bound material
[ 19]. Fig. 3 shows the effect of these treatments on residual levels
of cell associated [32p] MP-oligonucleotide. After incubation at
37°C, the bulk of the cell associated [32p] MP-oligonucleotide
is refractory to removal by low pH or trypsin, indicating that
it is within the cell; about 20-30% of the label was removed
by these treatments and thus seems to be on the cell surface. By
contrast, when cells were incubated at 4°C, and are thus unable
_3 _
Fig. 4. Subcellular distribution of TRITC labeled methylphosphonate
oligodeoxynucleotides. CHRC5 cells were pre-incubated with 2mg/mid FITC
labelled dextran at 370C for 1 hour in complete alpha-MEM medium, washed
and then incubated overnight. Cells pretreated with dextran were incubated with
4~tM TRITC labeled MP-oligonucleotides in HEPES buffer (pH 7.4) at 370C
for Ihour. Rhodamine and FITC images were monitored using the digitized
imaging system. (A) TRITC labeled MP-oligonucleotides; (B) corresponding image
with FITC dextran; (C) TRITC labeled MP-oligonucleotides; (D) same cell with
FITC dextran; (E) cells with free TRITC; (F) same cells with FITC dextran.
Numbers in C. D show points of coincidence of the TRITC and FITC images.
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to take up material by endocytosis, almost all of the cell associated
material could be removed by low pH or trypsin treatments. A
companion study [28] shows that MP-oligonucleotides are
strongly bound to lipid membranes; thus the presence of adsorbed
MP-oligonucleotide on the cell surface is not surprising.
Subcellular distribution of MP-oligonucleotides
Subcellular distribution patterns of TRITC labeled MP-
oligonucleotides were visualized by digitized video imaging. As
seen in Fig 4A, TRITC labelled MP-oligonucleotides showed
a punctate distribution with a tendency to accumulate in the
perinuclear region. There was also some diffuse fluorescence
apparently in the cytoplasm. Only a small amount of fluorescence
was observed in the nuclear region. The distribution of TRITC
labeled MP-oligonucleotides was compared, in the same cells,
with that of FITC labelled dextran, a marker of endocytic vesicles
and lysosomes[22,29]. Fig. 4B shows a partial co-distribution
of TRITC labeled MP-oligonucleotides with FITC-dextran, with
numerous vesicles found to contain both markers. This indicates
that some MP-oligonucleotides were internalized by the same
endocytotic pathway as dextran. This co-distribution was
observed up to 24 hours (data not shown), suggesting that intact
MP-oligonucleotides stay in lysosomal vesicles. This is consistent
with previous observations on the permeability characteristics of
endosomes/lysosomes, which suggest that only rather small
molecules can diffuse across the organelle membrane and enter
the cytoplasm [30]. The numbered arrows in Fig 4 C,D show
vesicles containing both TRITC labeled MP-oligonucleotides and
FITC-dextran; numbers are matched in both images. The
intracellular distribution of MP-oligonucleotides and dextran were
not entirely coincident, however, since the diffuse fluorescence
observed with the TRITC labeled MP-oligonucleotides was not
observed with the FITC-dextran. In addition, some vesicular
structures seemed to contain primarily one label or the other.
At this point it is not clear if the diffuse fluorescence obtained
with the TRITC labeled MP-oligonucleotides is due to
oligonucleotide in the cytoplasm, or oligonucleotide adsorbed to
the cell surface; as reported elsewhere [28], MP-oligonucleotides
can bind strongly to membranes. As shown in Fig.4D, free TRIT-
C was diffusely distributed into cytoplasmic regions with a
distinctively different distribution pattern than TRITC labeled
MP-oligonucleotides. Since FITC labeled dextran did not co-
localize with free TRITC, it seems clear that free TRITC was
not accumulated into endocytotic vesicles (Fig.4E). Control
experiments showed that no fluorescence was detected in FITC
loaded cells when the rhodamine filters were used, and no
fluorescence was detected in TRITC loaded cells when the
fluorescein filters were used.
Inhibition of uptake of MP-oligonucleotides
These experiments were carried out to determine whether specific
binding sites are involved in the uptake of MP-oligonucleotides,
as has been sugested for the uptake of phosphodiester
oligodeoxynucleotides [8,9]. Different concentrations of potential
competitors including unlabled D-oligonucleotides, MP-
oligonucleotides, or ATP were pre-incubated with cells for 15
min at 37°C. After pretreatment, [32p] labelled MP-oligonucleo-
tides were incubated for 3 hours at 37°C in the continued presence
of competitors. Cell viability was monitored by trypan blue
staining and no toxicity was observed. Fig. 5A shows the effects
of several potential competitors on cellular uptake of [32p]
MP-oligonucleotides. ATP did not significantly inhibit uptake
of MP-oligonucleotides even at very high concentration (10mM).
Inhibition of uptake of [32p] MP-oligonucleotides by unlabeled
D-oligonucleotide or MP-oligonucleotide was also modest, with
significant effects observed only at a 1000-fold excess. We also
tested the ability of various potential competitors to inhibit the
uptake of TRITC labeled MP-oligonucleotides. As seen in Fig
SB neither MP-oligonucleotides nor D-oligonucleotides
effectively inhibited uptake of TRITC labled MP-oligonucleo-
tides. By contrast, uptake of [32p] labeled D-oligonucleotide was
completely inhibited by unlabeled D-oligonucleotides in a dose
dependent manner (Fig.5C), confirming observations of other
investigators [5]. These results confirm previous observations
suggesting that the uptake of D-oligonucleotides involves specific
cell surface binding sites which are subject to competition. By
contrast, the uptake of MP-oligonucleotides does not seem to
involve saturable cell surface binding sites, and may thus be due
°T
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Fig. 5. Lack of inhibition of uptake of MP-oligodeoxynucleotides by competitors. Cells were incubated with competitors and radiolabeled D-, or MP-oligonucleotides
as described in Methods. (A) Inhibitory effects on uptake of [32p] labelled MP-oligonucleotides. Cells were incubated with 0.0l11M [32p] labeled MP-
oligodeoxynucleotide in alpha-MEM containing 10% heat inactivated FCS for 3 hour along with inhibitors as indicated. (B) Inhibitory effects on uptake of TRITC
labelled MP-oligonucleotides. TRITC labeled MP-oligodeoxynucleotides (41tM) were added to cells and incubated in HEPES buffer for 1 hour along with inhibitors
as indicated. (C) Dose dependent inhibition on uptake of D-oligonucleotides. Cells were incubated with 0.0liAM [32p] labeled D-oligodeoxynucleotide in HEPES
buffer for 3 hours along with excess unlabeled D-oligonucleotides. The numbers in A represent the concentration of inhibitor in uM; in B the concentation of inhibitor





















Fig. 6. Effect of acidification of cytosol on uptake of methylphosphonate
oligodeoxynucleotides. Cells were incubated in alpha-MEM containing 0.1 S% BSA
and buffered with HEPES (pHo=7.4) or MES (pHo=5.5) at 37°C for 30 min.
(A) shows the effect of acidification of cytosol on uptake of D, or MP-
oligonucleotides. Each experiment is in triplicate. Bars are standard deviations.
D-oligonucleotides (open ); MP-oligonucleotides (solid). (B) The intracellular pH
was measured using BCECF-AM loaded cells and the digitized imaging system
under both neutral pHo and acidic pHo conditions.
to fluid phase endocytosis or to non-specific adsorbtive
endocytosis [26,27,29].
Inhibition of receptor-mediated endocytosis
Since acidification of cytoplasmic pH inhibits receptor-mediated
endocytosis but not fluid phase endocytosis [24,27], the pathway
of internalization of MP-oligonucleotides was evaluated by
incubating the cells at normal or acidic cytoplasmic pH and
comparing the uptake of [32p] labeled MP oligonucleotides. As
shown in Fig.6B, cytosolic pH rapidly dropped (within 2min)
to around pH 5.7 when the external pH was changed to pH 5.5.
Cells were pre-incubated in HEPES-MEM (pH 7.4) or MES-
MEM(pH 5.5) buffer for 5 min prior to addition of [32p]
labelled MP-oligonucleotides; cells were then incubated at 37°C
for 30 min. As shown in Fig. 6A, uptake of D-oligonucleotides
in cells was completely inhibited when the cytosol was made
acidic. By contrast, uptake of MP-oligonucleotides was not
inhibited by acidification of the cytosol.
Lack of degradation of MP-oligonucleotides in cells
Our laboratory previously demonstrated that MP-oligonucleotides
were quite stable under tissue culture conditions while D-
oligonucleotides and S-oligonucleotides were degraded in 3 hours
[31]. The stability of intracellular MP-oligonucleotides is still
Fig. 7. Recovery of MP-oligonucleotides from cells and medium. [32p] labelled
MP-oligonucleotides were incubated with cells for 3 hrs at 37°C. Radiolabeled
material was recovered from cells and from culture medium as described in
Methods. The material was analyzed by denaturing PAGE and autoradiography.
A. Original oligonucleotide. B. Oligonucleotide recovered from medium. C.
Oligonucleotide recovered from cells.
unknown. To elucidate whether intracellular MP-oligonucleotides
are degraded or not, 5'-[32p] labelled MP-oligonucleotides were
recovered from cells and were analyzed by denaturing gel
electrophoresis (Fig.7). After 3 hours incubation at 37°C, intact
15 mer MP-oligonucleotides were recovered from the medium
(lane B) and from cells (lane C) with no degradation. By contrast,
the majority of D-oligonucleotide was rapidly degraded within
3 hours in medium or cells (data not shown).
DISCUSSION
In this report we used two different labels to investigate the
mechanism of cellular transport of oligodeoxynucleotides
containing methylphosphonate linkages. In contrast to early reports
which suggested that MP-oligonucleotides enter cells by passive
diffusion [ 13], we found that the dominant mechanism of cellular
uptake of MP-oligonucleotides seems to be via a fluid
phase/adsorbtive endocytotic route. This is also supported by work
in a companion report [28] showing that MP-oligonucleotides
cannot passively diffuse across phospholipid membranes at
significant rates. The uptake pathway for MP-oligonucleotides
appears to be distinct, however, from that for phosphodiester or
phosphorothioate oligodeoxynucleotides which seem to enter cells
by endocytosis involving a saturable binding site.
The MP-oligonucleotides used this study proved to be quite
stable both in culture medium and within cells. Thus the uptake
measurements reflect the behavior of the intact molecule and not
breakdown products. Since the nature of the 'tag' used to follow
uptake of an oligodeoxynucleotide might affect its behavior, we
used both [32P] and TRITC to label the MP-oligonucleotides.
Both labels provided similar results, indicating that the uptake
process was determined by the chemical characteristics of the
oligodeoxynucleotides and not that of the label. The use of
fluorescent TRITC labeled oligodeoxynucleotides also permitted
visualization of their intracellular distribution.
MP-oligonucleotides labeled with either 32p or TRITC
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uptake (Fig. 1, 2), which is characteristic of endocytosis but not
of passive diffusion [6,7,26]. However, uptake of labeled MP-
oligonucleotides was not readily competed by excess unlabeled
material, indicating that it is unlikely that specific cell surface
binding sites are involved in the endocytotic process (Fig.5). This
contrasts with the case of phosphodiester oligodeoxynucleotides
where excess unlabeled material blocks uptake of radiolabeled
oligodeoxynucleotides. Thus the uptake process for MP-
oligonucleotides may be fluid phase or adsorbtive endocytosis,
but is unlikely to be receptor mediated endocytosis. This
interpretation is also supported by experiments using acidification
of cytoplasmic pH to block receptor mediated endocytosis [27].
Sandvig et al [24] reported that cytoplasmic acidification inhibited
uptake of epidermal growth factor and transferrin, but did not
strongly affect uptake of ricin or lucifer yellow, markers of fluid-
phase endocytosis, indicating that a pH insensitive pathway is
responsible for fluid phase/adsorbtive endocytosis. Uptake of D-
oligonucleotide but not of MP-oligonucleotide was strongly
blocked by acidification of the cytoplasm (Fig 6). This result
clearly shows that the pathway of cellular uptake of MP-
oligonucleotides is distinct from that of D-oligonucleotides. Our
data also suggest that uptake of MP-oligonucleotides may involve
the fluid/adsorbtive endocytotic pathway defined by markers such
as lucifer yellow. Based on the fact that MP-oligonucleotides bind
strongly to membranes [28], adsorbtive endocytosis is likely to
be important. Thus, based on our work in CHO cells, there seems
to be more than one pathway for active endocytotic uptake of
oligonucleotides; however, the generality of these effects in
different cell types remains to be determined.
It should be noted that the oligonucleotides used in this study
contain 14 methylphosphonate linkages but retain a single
phosphodiester linkage and thus have a charge. It is conceivable
that oligonucleotides with all methylphosphonate linkages might
enter cells by a completely different mechanism such as passive
diffusion. However, we feel that this is unlikely. Although an
uncharged, fully methylphosphonate oligonucleotide may have
a greater oil-water partition coefficient than an oligonucleotide
with a single charge, the diffusion rate of such a large molecule
across the membrane bilayer is still likely to be very low
[7,32,33].
Use of a digitized video imaging system allowed visualization
of the intracellular distribution of TRITC labeled MP-
oligonucleotides. The distribution pattern suggested that the MP-
oligonucleotides were primarily confined to vesicular structures,
although some diffuse cytoplasmic fluorescence was also
observed; for the most part the nucleus remained dark indicating
little redistribution to that site during the course of the experiment.
The distribution pattern of TRITC labeled MP-oligonucleotides
overlapped substantially with that of fluoresceinated dextran
which is considered to be a good marker for endosomes and
lysosomes [22]. The fluorescence pattern observed for TRITC
labeled MP-oligonucleotide is unlikely to result from the re-
distribution of free TRITC cleaved from the oligodeoxynucleo-
tides, since quite a different pattern was observed when the cells
were incubated with free TRITC, one which did not show co-
localization with dextran. Thus the morphological evidence also
supports the concept that MP-oligonucleotides are primarily taken
up by endocytosis and accumulate in an endosomal/lysosomal
compartment.
Recently two groups have independently reported that
oligonucleotides microinjected into the cytoplasm, including MP-
oligonucleotides, were rapidly accumulated into the nucleus
[34,35]. In our studies, if MP-oligonucleotides escaped from the
lysosomal-endosomal compartment into the cytoplasm to any
great extent, then we should have observed redistribution to the
nucleus and strong nuclear fluorescence. Since this did not occur,
it seems likely that only a small portion of the MP-oligonucleotide
which accumulates in the cell gains entry into the cytoplasm. This
has interesting implications for the pharmacological actions of
oligonucleotides, suggesting that only a tiny fraction of the cell
associated material is responsible for the full pharmacological
effects. It also suggests that endosome to cytoplasm transfer may
be a critical limiting step for the pharmacological actions of highly
charged oligonucleotides such as D-oligonucleotides and S-oligo-
nucleotides, as well as for chemically modified oligonucleotides
containing nonpolar substituents, such as MP-oligonucleotides,
since both types accumulate in the endosomal compartment. Thus
delivery strategies which facilitate endosome to cytosol transfer
may be of value in the successful therapeutic application of oligo-
nucleotides.
ACKNOWLEDGEMENT
This work was supported by NIH grant CA47044 to RLJ.
REFERENCES
1. Cohen JS. (1989) Trends in Pharm. Sci. 10:435-37
2. Agrawal S, Ikeuchi T, Sun D, Sarin PS, Konopka A, Maizel, and Zamecnik,
PC. (1989) Proc. Natd. Acad. Sci. USA, 86:7790-4
3. Matsukura M, K Shinozuka, G. Zon, H Mitsuya, M. Reitz, JS Cohen and
S Broder. (1987) Proc. Natl. Acad. Sci. USA 84:7706-7710
4. Smith CC, L Aurelian, M Reddy, PS Miller, POP Ts'O. (1986) Proc. Natd.
Acad. Sci. USA 83:2787-2791
5. Helene C and Toulme JJ. (1990) Biochim. Biophys Acta. 1049:99-125
6. Jain, MK.(1988) Introduction to Biological Membranes. J. Wiley, N.Y.
7. Gennis, RB. (1989) Biomembranes, Springer Verlag, NY
8. Loke SL, Stein CA, Zhang XH, Mori K, Nakanishi M, Subasinghe C, Cohen
JS, and Neckers LM (1989) Proc. Natl. Acad. Sci.USA 86:3474-3478
9. Yakubov LA, Deeva EA, Zarytova VF, Ivanova EM, Ryte AS, Yurchenko
LV, and Vlassov VV (1989) Proc. Nadl. Acad. Sci. USA 86:6454-6458
10. Wickstrom, ER. (1986) J. Biochem. Biophys. Meth. 13:97-102
11. Zon, G. (1988) Pharmaceut. Res. 5: 539-48
12. Stein CA, Mori K, Loke SL, Subasinghe C, Shinozuka K, Cohen JS and
Neckers LM (1988) Gene 72:333-341
13. Miller PS, McFarland KB, Jayaraman K and Ts'o POP (1981) Biochemistry
20:1874-1880
14. Jaroszewski JW & Cohen JS (1991) Adv. Drug Delivery Rev., in press
15. Bradley G., Juranka P., and Ling V (1988) Biochim. Biophys Acta. 948:
87-128
16. Applied Biosystems User Bulletin No. 43. (1987). Applied Biosystems, Foster
City, CA
17. Applied Bionetics Inc, (ABN) literature as suplied on purchase of methyl
phosphonamidate synthons for automated oligonucleotide synthesis. Applied
Bionetics Inc, Hayward, CA.
18. Daoud SS and Juliano R.L (1989) Cancer Res. 49:2661-2667
19. Sczekan ML. and Juliano RL (1990) J. Cell. Physiol. 142:574-580
20. DeGuiseppi J, Inmann R, Ishihara A, Jacobson K, Herman B (1985) BioTech.
3:394-403
21. Lemasters JJ, DiGuiseppi J, Nieminen AL, Herman B (1987) Nature
325:78-81
22. Yamashiro DJ and Maxfield FR (1987) J. Cell Biol. 105:2713-21
23. Davoust J, Gruengerg J, and Howell KE (1987) EMBO J. 6:3601-3609
24. Sandvig K, Olsnes S, Petersen OW, van Deurs B (1987) J. Cell Biol.
105:679-689
25. Gores GJ, Nieminen AL, Wray BE, Herman B, Lemasters J (1988) J. Clin.
Invest. 83:386-396
26. Steinman RM, Mellman IS, Muller WA, and Cohn ZA (1983) J. Cell Biol.
96: 1-27
27. VanDeurs, B et al. (1989) Int. Rev. Cytol. 117:131-79
5550 Nucleic Acids Research, Vol. 19, No. 20
28. Akhtar, S et al. (1991) submitted
29. McGraw, T and Maxfield, F (1991) in Handbook of Experimental
Pharmacology v. 100, Springer Verlag, Heidelberg
30. Ehrenreich BA and Cohn ZA (1969) J. Exp. Med.129:227-45
31. Akhtar S, Kole, R and Juliano, RL (1991) Life Sciences, in press
32. Wolosin JM, Ginsburg H, Lieb WR, and Stein WD (1978) J. Gen. Physiol.
71:93-100
33. Lieb WR and Stein WD (1986) J. Membr. Biol. 92:111-9
34. Chin DJ, Green GA, Zon G, Szoka FC and Straubinger RM (1990) The
New Biologist. 2: 1091-1100
35. Leonetti JP, Mechti N, Degols G, Gagnor C, and LeBleu B (1991) Proc.
Natl. Acad. Sci. US 88:2702-6
Note added
Following submission of this work we became aware of a recent
publication indicating heterogeneous uptake of oligonucleotides
in lymphoid cells; only some of the uptake was completed by
DNA, thus suggesting fluid phase endocytosis.
Krieg,A.M., Meyling,F.G., Gourley,M.F., Kisch,W.J., Chrisey,L.A. and
Steinberg,A. D. (199 1) Antisense Research and Development, 1:161-17 1.
